First Trust Capital Management’s ProKidney PROK Stock Holding History
Bought
Maintained
Sold
Other funds holding PROK
SCM
BL
CS
MCM
First Trust Capital Management's PROK Position: Q3 2022 in Review
First Trust Capital Management sold out of ProKidney (PROK) in Q3 2022, closing a stake of 847,315 shares — an estimated $8.38M sold.
First Trust Capital Management first reported a position in PROK in Q1 2022 and held it in 2 quarters. The position peaked at $8.38M in Q2 2022. 18 funds tracked by Wall St. Rank hold PROK as of Q3 2022.
- First Trust Capital Management reported no remaining ProKidney position as of Q3 2022 after selling out during the quarter.
- First Trust Capital Management sold 847,315 ProKidney shares in Q3 2022, an estimated $8.38M.
- First Trust Capital Management first reported a position in ProKidney in Q1 2022 and held it in 2 quarters.
- First Trust Capital Management's ProKidney position peaked at $8.38M in Q2 2022.
- 18 funds tracked by Wall St. Rank held ProKidney as of Q3 2022.
Based on First Trust Capital Management's 13F filing for Q3 2022, filed 14 Nov 2022.